A study from the Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan has reported that “CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses”
This study was published in the July 08, 2014 Journal of Clinical Investigation (I.F>15) by Prof. Masatoshi Hagiwara, Makoto Yamamoto and others from the Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: MiRNAs-based Antiviral therapy: Mirn-1 inhibits replication of human herpesvirus 1 and 2 (HHV-1 and HHV-2) via down regulation of its target gene. This study suggests that Mirn-1, by down regulating its target gene, it may inhibit the replication of human herpesvirus 1 and 2 (HHV-1 and HHV-2). Thereby, it may inhibit the pathogenesis and progression of HHV-induced diseases. Together, this study suggests that pharmacological formulations encompassing “MiRN-1 or its activators” can be used to inhibit HHV-induced diseases.
Idea Proposed/Formulated by: Dr L Boominathan PhD
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Courtesy: When you cite drop us a line at info@genomediscovery.org
Citation: Boominathan, MiRNAs-based Antiviral therapy: Mirn-1 inhibits replication of human herpesvirus 1 and 2 (HHV-1 and HHV-2) via down regulation of its target gene, 15/July/2014, 7.07 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
*Research cooperation
